Alpha Healthcare Acquisition Corp. | Business Contracts

Executive Separation and Release Agreement, dated December 23, 2021, between Jeffrey Lawson, M.D. and Humacyte, Inc (Filed With SEC on March 29, 2022)

Sixth Amendment to Exclusive Patent License Agreement, dated January 10, 2022, between Duke University and Humacyte Global, Inc (Filed With SEC on March 29, 2022)

Description of the Companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 29, 2022)

Second Amendment to Loan and Security Agreement, dated as of September 17, 2021, by and among Humacyte, Inc., Humacyte Global, Inc., Silicon Valley Bank and SVB Innovation Credit... (Filed With SEC on September 17, 2021)

First Amendment to Supply Agreement, dated October 12, 2018, between SeraCare Life Sciences, Inc. and Humacyte, Inc (Filed With SEC on March 23, 2021)

Lease Agreement, dated December 31, 2015, between ARE-NC Region No.5, LLC and Humacyte, Inc (Filed With SEC on March 23, 2021)

Business Combination Agreement, dated as of February 17, 2021, by and among Alpha Healthcare Acquisition Corp., Hunter Merger Sub, Inc. and Humacyte, Inc (Filed With SEC on February 17, 2021)

Humacyte, Inc. Annual Bonus Plan (Filed With SEC on August 30, 2021)

Humacyte, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on August 30, 2021)

Form of Stock Option Agreement under Humacyte, Inc. 2021 Long-Term Incentive Plan (Filed With SEC on August 30, 2021)

Humacyte, Inc. 2021 Long-Term Incentive Plan (Filed With SEC on August 30, 2021)

Amendment to Executive Employment Agreement, dated February 3, 2021, between Jeffrey Lawson, M.D. and Humacyte, Inc (Filed With SEC on March 23, 2021)

First Amendment of Humacyte, Inc. 2005 Stock Option Plan, dated March 31, 2008 (Filed With SEC on March 23, 2021)

Humacyte, Inc. 2005 Stock Option Plan (Filed With SEC on March 23, 2021)

Executive Employment Agreement, dated September 13, 2019, between Heather Prichard, Ph.D. and Humacyte, Inc (Filed With SEC on March 23, 2021)

Executive Employment Agreement, dated October 8, 2018, between Douglas Blankenship and Humacyte, Inc (Filed With SEC on March 23, 2021)

Executive Employment Agreement, dated June 19, 2018, between Jeffrey Lawson, M.D. and Humacyte, Inc (Filed With SEC on March 23, 2021)

Executive Employment Agreement, dated February 3, 2021, between Laura Niklason, M.D., Ph.D. and Humacyte, Inc (Filed With SEC on March 23, 2021)

Supply Agreement, dated August 31, 2015, between Confluent Medical Technologies (formerly known as Biomedical Structures LLC) and Humacyte, Inc (Filed With SEC on March 23, 2021)

Third Amendment of Humacyte, Inc. 2005 Stock Option Plan, dated November 22, 2013 (Filed With SEC on March 23, 2021)

Supply Agreement, dated January 9, 2014, between SeraCare Life Sciences, Inc. and Humacyte, Inc (Filed With SEC on March 23, 2021)

Second Amendment of Humacyte, Inc. 2005 Stock Option Plan, dated October 28, 2011 (Filed With SEC on March 23, 2021)

Second Amendment to Humacyte, Inc. 2015 Omnibus Incentive Plan, dated June 6, 2018 (Filed With SEC on March 23, 2021)

Form of Incentive Stock Option Agreement under Humacyte, Inc. 2005 Stock Option Plan (Filed With SEC on March 23, 2021)

Form of Nonstatutory Stock Option Agreement under Humacyte, Inc. 2005 Stock Option Plan (Filed With SEC on March 23, 2021)

Humacyte, Inc. 2015 Omnibus Incentive Plan (Filed With SEC on March 23, 2021)

First Amendment to Humacyte, Inc. 2015 Omnibus Incentive Plan, dated February 23, 2018 (Filed With SEC on March 23, 2021)

Fourth Amendment to Exclusive Patent License Agreement, dated January 2, 2018, between Duke University and Humacyte, Inc (Filed With SEC on March 23, 2021)

Form of Incentive Stock Option Agreement under Humacyte, Inc. 2015 Omnibus Incentive Plan (Filed With SEC on March 23, 2021)

Form of Nonstatutory Stock Option Agreement under Humacyte, Inc. 2015 Omnibus Incentive Plan (Filed With SEC on March 23, 2021)

Annual Bonus Plan (Filed With SEC on March 23, 2021)

First Amendment to Lease, dated September 30, 2016, between ARE-NC Region No.5, LLC and Humacyte, Inc (Filed With SEC on March 23, 2021)

Second Amendment to Lease, dated February 8, 2017, between ARE-NC Region No.5, LLC and Humacyte, Inc (Filed With SEC on March 23, 2021)

Third Amendment to Lease, dated April 21, 2017, between ARE-NC Region No.5, LLC and Humacyte, Inc (Filed With SEC on March 23, 2021)

Fourth Amendment to Lease, dated October 31, 2017, between ARE-NC Region No.5, LLC and Humacyte, Inc (Filed With SEC on March 23, 2021)

Fifth Amendment to Exclusive Patent License Agreement, dated December 31, 2019, between Duke University and Humacyte, Inc (Filed With SEC on March 23, 2021)

Third Amendment to Exclusive Patent License Agreement, dated June 26, 2015, between Duke University and Humacyte, Inc (Filed With SEC on March 23, 2021)

Distribution Agreement, dated June 25, 2018, by and between Fresenius Medical Care Holdings, Inc. and Humacyte, Inc (Filed With SEC on March 23, 2021)

First Amendment to Exclusive Patent License Agreement, dated February 25, 2011, between Duke University and Humacyte, Inc (Filed With SEC on March 23, 2021)

Exclusive Patent License Agreement, dated March 14, 2006, between Duke University and Humacyte, Inc (Filed With SEC on March 23, 2021)

Exclusive License Agreement, dated August 25, 2019, by and between Yale University and Humacyte, Inc (Filed With SEC on March 23, 2021)

Exclusive License Agreement, dated August 13, 2019, by and between Yale University and Humacyte, Inc (Filed With SEC on March 23, 2021)

Exclusive License Agreement, dated February 25, 2014, by and between Yale University and Humacyte, Inc (Filed With SEC on March 23, 2021)

Second Amendment to Distribution Agreement, effective as of February 16, 2021, by and between Fresenius Medical Care Holdings, Inc. and Humacyte, Inc (Filed With SEC on March 23, 2021)

First Amendment to Distribution Agreement, dated October 2, 2019, by and between Fresenius Medical Care Holdings, Inc. and Humacyte, Inc (Filed With SEC on March 23, 2021)

Second Amendment to Exclusive Patent License Agreement, dated April 24, 2014, between Duke University and Humacyte, Inc (Filed With SEC on March 23, 2021)

Form of Subscription Agreement (Filed With SEC on March 23, 2021)

Form of Subscription Agreement (Filed With SEC on February 17, 2021)

Description of the Companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on February 16, 2021)

Letter Agreement, dated September 17, 2020, by and among the Company, its officers, its directors and the Sponsor (Filed With SEC on September 22, 2020)

Registration Rights Agreement, dated September 17, 2020, by and among the Company and certain security holders (Filed With SEC on September 22, 2020)

Warrant Agreement, dated September 17, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Filed With SEC on September 22, 2020)

Underwriting Agreement, dated September 17, 2020, by and between the Company and Oppenheimer & Co. Inc., as representative of the several underwriters (Filed With SEC on September 22, 2020)

Investment Management Trust Agreement, dated September 17, 2020, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on September 22, 2020)

Administrative Support Agreement, dated September 17, 2020, by and between the Company and Constellation Alpha Holdings LLC (Filed With SEC on September 22, 2020)

Unit Subscription Agreement, dated September 17, 2020, by and between the Company and the Sponsor (Filed With SEC on September 22, 2020)

Unit Subscription Agreement, dated September 17, 2020, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on September 22, 2020)

Unit Subscription Agreement, dated September 17, 2020, by and between the Company and Northland Securities, Inc (Filed With SEC on September 22, 2020)

Form of Underwriting Agreement (Filed With SEC on September 14, 2020)

Specimen Unit Certificate (Filed With SEC on September 1, 2020)

Form of Administrative Support Agreement by and between the Registrant and Constellation Alpha Holdings LLC (Filed With SEC on September 1, 2020)

Form of Indemnity Agreement (Filed With SEC on September 1, 2020)

Form of Placement Unit Purchase Agreement between the Registrant and the Underwriters (Filed With SEC on September 1, 2020)

Form of Placement Unit Purchase Agreement between the Registrant and AHAC Sponsor LLC (Filed With SEC on September 1, 2020)

Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on September 1, 2020)

Form of Investment Management Trust Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on September 1, 2020)

Form of Letter Agreement among the Registrant and our officers, directors and AHAC Sponsor LLC (Filed With SEC on September 1, 2020)

Form of Warrant Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on September 1, 2020)

Specimen Warrant Certificate (Filed With SEC on September 1, 2020)

Specimen ClassA Common Stock Certificate (Filed With SEC on September 1, 2020)

Securities Subscription Agreement, dated July 20, 2020, between the Registrant and AHAC Sponsor LLC (Filed With SEC on August 4, 2020)

Promissory Note, dated July 20, 2020, issued to AHAC Sponsor LLC (Filed With SEC on August 4, 2020)

Alpha Healthcare Acquisition Corp. (72)